𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Crohn's disease: systematic review of assessment of disease severity and its relevance to surgery

✍ Scribed by P. K. Dhruva Rao; M. Davies; P. E. Price; J. Torkington


Book ID
109042809
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
84 KB
Volume
9
Category
Article
ISSN
1462-8910

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Incidence and clinical significance of i
✍ Andrea Cassinotti; Simon Travis πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

Background: Infliximab (IFX) is a chimeric (mouse/human) anti-TNF-alpha monoclonal antibody approved for the treatment of refractory luminal and fistulizing Crohn's disease (CD). It is a source of potential immunogenicity for humans, with the occurrence of anti-infliximab antibodies (ATIs), which ar